BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3027685)

  • 21. [Breast cancer].
    Van Bogaert LJ
    Rev Fr Gynecol Obstet; 1984 May; 79(5):361-98. PubMed ID: 6098952
    [No Abstract]   [Full Text] [Related]  

  • 22. [Morphologic studies of the stroma of breast cancers].
    Müller H; Schmidts HL; Sakuma T; Stutte HJ
    Verh Dtsch Ges Pathol; 1985; 69():264-8. PubMed ID: 3006381
    [No Abstract]   [Full Text] [Related]  

  • 23. Benign and malignant proliferative epithelial lesions of the breast; a review.
    Azzopardi JG
    Eur J Cancer Clin Oncol; 1983 Dec; 19(12):1717-20. PubMed ID: 6319145
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunohistochemical localization of myoepithelial cells and basement membrane in normal, benign and malignant human breast lesions.
    Tsubura A; Shikata N; Inui T; Morii S; Hatano T; Oikawa T; Matsuzawa A
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(2):133-9. PubMed ID: 2838950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The concept and implications of multicentricity in breast carcinoma.
    Lagios MD; Westdahl PR; Rose MR
    Pathol Annu; 1981; 16(Pt 2):83-102. PubMed ID: 6276850
    [No Abstract]   [Full Text] [Related]  

  • 27. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value and prognostic significance of alpha-lactalbumin (ALA), lactoferrin (Lfr) and HMFG-2 in primary breast cancers. An immunohistochemical study].
    Wrba F; Ritzinger E; Reiner A; Holzner JH
    Pathologe; 1987 Jan; 8(1):25-30. PubMed ID: 3031642
    [No Abstract]   [Full Text] [Related]  

  • 29. [CEA, grade and stage in breast carcinoma. Immunohistochemical study of 40 cases].
    Sironi M; Cantaboni A
    Pathologica; 1984; 76(1044):427-36. PubMed ID: 6096797
    [No Abstract]   [Full Text] [Related]  

  • 30. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
    Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
    Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Histo-prognostic elements in breast cancer].
    Jacquemier J; Bonneau HP
    J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):200-8. PubMed ID: 209077
    [No Abstract]   [Full Text] [Related]  

  • 32. [Early diagnosis of breast cancer].
    Mohr HJ; Mainzer FG
    Pathologe; 1980 Nov; 2(1):44-7. PubMed ID: 6258169
    [No Abstract]   [Full Text] [Related]  

  • 33. [Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery].
    Bässler R
    Strahlenther Onkol; 1996 Feb; 172(2):110-1. PubMed ID: 8669044
    [No Abstract]   [Full Text] [Related]  

  • 34. [The concept of carcinoma in situ].
    Andersen JA; Schiødt T
    Ugeskr Laeger; 1980 Mar; 142(14):867-9. PubMed ID: 6250258
    [No Abstract]   [Full Text] [Related]  

  • 35. Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast.
    Sahoo S; Recant WM
    Breast J; 2005; 11(2):140-2. PubMed ID: 15730461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic immunohistochemistry of breast epithelial lesions].
    Balaton AJ; Guinebretière JM; Penault-Llorca F
    Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Carcinoma of the female breast. Morphological aspects].
    Silva JN
    Arq Patol; 1972 Aug; 43(2):109-20. PubMed ID: 4343609
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathological aspects of breast cancer screening.
    Elston CW
    Aust N Z J Surg; 1988 May; 58(5):355-63. PubMed ID: 2845907
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fine needle aspiration of the breast: diagnostic criteria.
    Oertel YC; Galblum LI
    Pathol Annu; 1983; 18 Pt 1():375-407. PubMed ID: 6308547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.